About Us


SpectraDigital Corporation (SDC) is a technology company that specializes in the development of simple, easy-to-use, medical diagnostic tests for use in low-resource settings. SDC is also actively engaged in developing agricultural applications.

The SpectraDigital platform can be adapted for use in a variety of applications. HIV SpectraPoint, is our first application that assesses the efficacy of AIDS anti-virals using a simple blood test. This method can provide information similar to the genotype/phenotype test at a much lower cost making access to diagnostics more accessible.

Other uses for SDC’s platform include developing lead chemistries, drug assessment, evaluating the efficacy of drugs, environmental monitoring, and other settings involving the measurement of cellular reactions and cellular response to metabolic agents.

Advantages of SDC’s technology platform include:



BOARD OF DIRECTORS



ADVISORY BOARD


Dr. Peter Krell, Ph.D.
Dr. Krell is a virologist by training and on the faculty at the Department of Molecular and Cellular Biology, University of Guelph. Dr. Krell studies animal viruses, and in particular, fowl adenoviruses as vectors to produce subunit or live viral vaccines for several animal viral diseases. He has recently begun collaboration on influenza virus research.

Dr. Anne-Marie Zajdlik, M.D.
Dr. Zajdlik is the founder of the Masai Centre for Local, Regional and Global Health, which offers holistic treatment for those living with HIV/AIDS. Anne-Marie also practices family medicine in Guelph, Ontario.

Dr. Ian Crandall, Ph.D.
Dr. Crandall is on faculty at the University of Toronto and specializes in malaria diagnostics, testing anti-malaria drugs, and cell culture studies.

Dr. Gurdip Singh, M.D.
Dr. Gurdip Tamber is a graduate of the North-Western State Medical University, Mechnikov, Russia. He also holds a Bachelor of Science degree (Major in Microbiology and Immunology) from McGill University. He has been involved in various research projects at the Public Health Laboratory, Ontario, Mount Sinai Hospital (Microbiology Department) and Mcgill University’s Urology Department. Recently, he has been involved in the study of new arising bacteria known as Streptococcus pseudopneumoniae, and investigating Acanthamoeba. He advises SpectraDigital on medical diagnostics and epidemiology.